» Articles » PMID: 28733133

Navigating the Gut Buffet: Control of Polysaccharide Utilization in Bacteroides Spp

Overview
Date 2017 Jul 23
PMID 28733133
Citations 56
Authors
Affiliations
Soon will be listed here.
Abstract

Bacteroides spp. are members of the human gut microbiota that confer myriad benefits on their hosts. Among them is the provision of energy from otherwise indigestible polysaccharides comprising part of the host diet, lining the intestinal mucosal layer, and decorating the surface of other microbes. Bacteroides spp. devote ∼20% of their genomes to the transport and breakdown of a wide variety of polysaccharides, and to the regulation of these processes. Bacteroides spp. rely on different families of transcriptional regulators to ensure that carbohydrate utilization genes are expressed under specific conditions. The regulators and mechanisms controlling carbohydrate utilization are often unique to these gut-dwelling bacteria, and do not conform to those of model organisms.

Citing Articles

Transcriptional delineation of polysaccharide utilization loci in the human gut commensal DSM18205 and co-culture with exemplar species on dietary plant glycans.

Panwar D, Briggs J, Fraser A, Stewart W, Brumer H Appl Environ Microbiol. 2024; 91(1):e0175924.

PMID: 39636128 PMC: 11784079. DOI: 10.1128/aem.01759-24.


Screening and Functional Prediction of Rumen Microbiota Associated with Methane Emissions in Dairy Cows.

Bao J, Wang L, Li S, Guo J, Ma P, Huang X Animals (Basel). 2024; 14(22).

PMID: 39595248 PMC: 11591143. DOI: 10.3390/ani14223195.


Didymin Ameliorates Dextran Sulfate Sodium (DSS)-Induced Ulcerative Colitis by Regulating Gut Microbiota and Amino Acid Metabolism in Mice.

Chu Z, Hu Z, Yang F, Zhou Y, Tang Y, Luo F Metabolites. 2024; 14(10).

PMID: 39452928 PMC: 11509612. DOI: 10.3390/metabo14100547.


Determinants of raffinose family oligosaccharide use in species.

Basu A, Adams A, Degnan P, Vanderpool C J Bacteriol. 2024; 206(10):e0023524.

PMID: 39330254 PMC: 11501099. DOI: 10.1128/jb.00235-24.


Advancements in gene editing technologies for probiotic-enabled disease therapy.

Wang L, Hu J, Li K, Zhao Y, Zhu M iScience. 2024; 27(9):110791.

PMID: 39286511 PMC: 11403445. DOI: 10.1016/j.isci.2024.110791.